Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
VSEE Stock Forecast 2025-2026
$0.55
Current Price
$17.73M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to VSEE Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
VSEE Price Momentum
-1.8%
1 Week Change
-43.9%
1 Month Change
-65.6%
1 Year Change
-59.6%
Year-to-Date Change
-78.2%
From 52W High of $2.52
+20.7%
From 52W Low of $0.46
📊 TOP ANALYST CALLS
Did VSEE Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if VSee Health is one of their latest high-conviction picks.
Latest VSEE Stock Price Targets & Analyst Predictions
VSEE has shown a year-to-date change of -59.6% and a 1-year change of -65.6%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for VSEE. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
VSEE Analyst Ratings
1
Buy
0
Hold
0
Sell
VSEE Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.55
Latest VSEE Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for VSEE.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 24, 2025 | Maxim Group | Allen Klee | Buy | Initiates | $5.00 |
Vsee Health Inc. (VSEE) Competitors
The following stocks are similar to VSee Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Vsee Health Inc. (VSEE) Financial Data
Vsee Health Inc. has a market capitalization of $17.73M with a P/E ratio of 1.2x. The company generates $14.43M in trailing twelve-month revenue with a -69.8% profit margin.
Revenue growth is +18.7% quarter-over-quarter, while maintaining an operating margin of -51.7% and return on equity of +312,105.2%.
Valuation Metrics
Market Cap
$17.73M
Enterprise Value
$28.71M
P/E Ratio
1.2x
PEG Ratio
0.0x
Price/Sales
1.2x
Growth & Margins
Revenue Growth (YoY)
+18.7%
Gross Margin
+52.1%
Operating Margin
-51.7%
Net Margin
-69.8%
EPS Growth
+132.6%
Financial Health
Cash/Price Ratio
+2.7%
Current Ratio
0.2x
Debt/Equity
-2.0x
ROE
+312,105.2%
ROA
-26.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Vsee Health Inc. (VSEE) Business Model
About Vsee Health Inc.
What They Do
Provides telemedicine solutions for healthcare delivery.
Business Model
The company operates a comprehensive telemedicine platform that integrates various services such as video conferencing, secure messaging, and mobile health monitoring. It generates revenue by partnering with healthcare providers, medical institutions, and government agencies to deliver virtual consultations and remote patient management services.
Additional Information
Vsee Health Inc. aims to enhance healthcare access, particularly in underserved areas, and is positioned at the forefront of the shift towards digital health, focusing on patient-centered and technology-driven healthcare solutions.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
154
CEO
Dr. Imoigele P. Aisiku M.B.A., M.D.
Country
United States
IPO Year
2021
Website
www.vseehealth.comVsee Health Inc. (VSEE) Latest News & Analysis
Latest News
VSee and Novant Health Urgent Care Share Blueprint for Scalable, Profitable Tele-Urgent Programs
2 days ago
Quick Summary
VSee Health (Nasdaq: VSEE) will host a webinar with Novant Health Urgent Care today, showcasing strategies for effective virtual urgent-care programs amid growing market demand for telehealth solutions.
Why It Matters
VSee Health's partnership with Novant Health underscores its market leadership in AI telehealth, signaling growth potential and operational efficiency in virtual care, crucial for investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
VSee Health, Inc. (NASDAQ:VSEE) has secured a $6.0 million agreement to sell 9.8 million shares and warrants for 19.7 million shares at $0.61 each, pending shareholder approval.
Why It Matters
VSee Health's securities deal raises $6 million, enhancing liquidity for growth. The issuance of warrants could dilute shares but signals investor confidence in future performance.
Source: Accesswire
Market Sentiment:
Neutral
VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!
11 days ago
Quick Summary
VSee Health, Inc. (NASDAQ:VSEE) reports progress in fulfilling contracts via its iDoc platform, activating hospitals and scaling services, leading to real revenue growth.
Why It Matters
VSee Health's active contract fulfillment and revenue growth signal strong operational execution, potentially boosting investor confidence and stock performance.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
VSee Health, Inc. (Nasdaq: VSEE) appointed Dr. Milton Chen as Chairman of the Board, enhancing leadership as the company accelerates its AI infrastructure growth.
Why It Matters
Dr. Chen's appointment signals a focused strategy on AI growth, potentially enhancing VSee Health's market position and attracting investor interest in its innovative capabilities.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
VSee Health, Inc. (Nasdaq: VSEE) reported Q3 2025 revenues of $3.98 million, a 19% increase from $3.35 million year-over-year, driven by increased demand for telehealth services.
Why It Matters
VSee Health's 19% revenue growth signals strong demand for its telehealth solutions, suggesting potential for continued expansion and profitability, influencing investor sentiment positively.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
VSee Health, Inc. (Nasdaq:VSEE) has secured FedRAMP Moderate authorization, allowing it to offer telehealth services to federal agencies. It is also integrating robotic assistance in ICUs for remote monitoring.
Why It Matters
VSee Health's FedRAMP authorization enhances its market position, opening federal contracts. The integration of robotics in ICUs could significantly elevate revenue and growth potential.
Source: Accesswire
Market Sentiment:
Neutral
Frequently Asked Questions About VSEE Stock
What is Vsee Health Inc.'s (VSEE) stock forecast for 2026?
Analyst forecasts for Vsee Health Inc. (VSEE) are not currently available. The stock is trading at $0.55.
Is VSEE stock a good investment in 2026?
According to current analyst ratings, VSEE has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.55. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for VSEE stock?
Price predictions from Wall Street analysts for VSEE are not currently available. The stock is trading at $0.55.
What is Vsee Health Inc.'s business model?
The company operates a comprehensive telemedicine platform that integrates various services such as video conferencing, secure messaging, and mobile health monitoring. It generates revenue by partnering with healthcare providers, medical institutions, and government agencies to deliver virtual consultations and remote patient management services.
What is the highest forecasted price for VSEE Vsee Health Inc.?
Price targets from Wall Street analysts for VSEE are not currently available. The stock is trading at $0.55.
What is the lowest forecasted price for VSEE Vsee Health Inc.?
Price targets from Wall Street analysts for VSEE are not currently available. The stock is trading at $0.55.
What is the overall VSEE consensus from analysts for Vsee Health Inc.?
The overall analyst consensus for VSEE is bullish. Out of 1 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell.
How accurate are VSEE stock price projections?
Stock price projections, including those for Vsee Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 7, 2025 4:42 AM UTC